YALE UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 72
- Registration Number
- NCT00142883
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Environmental Treatment for Seasonal Affective Disorder (SAD)
- Conditions
- Interventions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2013-03-06
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT00139997
- Locations
- 🇨🇦
Douglas Hospital Research Centre, Montreal, Quebec, Canada
🇳🇱University Medical Center Groningen, Groningen, RB, Netherlands
🇨🇦University of British Columbia, Vancouver, British Columbia, Canada
Usefulness of Selegiline as an Aid to Quit Smoking - 1
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Yale University
- Target Recruit Count
- 101
- Registration Number
- NCT00129311
- Locations
- 🇺🇸
PRISM, New Haven, Connecticut, United States
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 40
- Registration Number
- NCT00129246
- Locations
- 🇺🇸
Yale University School of Medicine Substance Abuse Treatment Unit, New Haven, Connecticut, United States
Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate
- Conditions
- First Posted Date
- 2005-07-18
- Last Posted Date
- 2012-09-19
- Lead Sponsor
- Yale University
- Registration Number
- NCT00120640
Targeted Interventions for Weight-Concerned Smokers
- Conditions
- Interventions
- First Posted Date
- 2005-03-15
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Yale University
- Target Recruit Count
- 172
- Registration Number
- NCT00105482
- Locations
- 🇺🇸
Yale University School of Medicine Substance Abuse Treatment Unit, New Haven, Connecticut, United States
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
- First Posted Date
- 2005-03-04
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 20
- Registration Number
- NCT00104975
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
Framing Messages for Smoking Cessation With Bupropion - 6
- Conditions
- Interventions
- First Posted Date
- 2005-03-02
- Last Posted Date
- 2013-08-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 252
- Registration Number
- NCT00104598
- Locations
- 🇺🇸
Substance Abuse Treatment Unit, New Haven, Connecticut, United States
Insulin Resistance Intervention After Stroke Trial
- Conditions
- Interventions
- First Posted Date
- 2004-09-22
- Last Posted Date
- 2020-04-27
- Lead Sponsor
- Yale University
- Target Recruit Count
- 3876
- Registration Number
- NCT00091949
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸University of South Alabama, Mobile, Alabama, United States
🇺🇸Shanti Clinical Trials (NINDS-CRC site), Colton, California, United States
Aminocamptothecin in Treating Patients With T-cell Lymphoma
- Conditions
- First Posted Date
- 2004-08-11
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 12
- Registration Number
- NCT00002635
- Locations
- 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸New England Medical Center Hospital, Boston, Massachusetts, United States